Answers are grounded in this paper and cite their sources.
As the inducible component of the activator protein-1 (AP-1) transcription factor complex, c-Fos acts as a critical hub translating extracellular immune stimuli into context-specific transcriptional programs. This review outlines the mechanistic roles of c-Fos/AP-1 in immune regulation and inflammatory diseases, from inflammatory activation and regulation to tissue remodeling. We dissect how diverse upstream signals—including TLR4, TCR, FcϵRI, and RANK—converge on MAPK cascades (ERK1/2, JNK, and p38), and how cytokines like IL-6 engage JAK-STAT signaling to regulate c-Fos expression in a context-dependent manner. Following induction, c-Fos-containing AP-1 complexes form through heterodimerization with Jun family proteins and cooperate with NF-κB and NFAT to regulate pro-inflammatory cytokine production, osteoclastogenesis, tissue injury, and other cell-specific transcriptional programs. Furthermore, we discuss emerging evidence on c-Fos-mediated regulatory mechanisms that shape the magnitude and duration of inflammation across different cellular contexts. Finally, we evaluate current therapeutic strategies targeting the c-Fos/AP-1 axis, using the small-molecule inhibitor T-5224 as a case study, and address the challenges of cell-type-specific functions. We propose that selectively targeting pathological c-Fos/AP-1 activity while preserving physiological functions holds promise for precision immunomodulation in inflammatory disorders.
No takes yet. Share an insight, caveat, or question.
You et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: